JournalsHub
.online
Find My Journal
AB

Alberto Bardelli

European School of Molecular Medicine IT

ORCID iD 0000-0003-1647-5070
927
Publications
72,932
Citations
115
H-Index
288
i10-Index
5.97
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies OA
Chetan Bettegowda, Mark Sausen, Rebecca Leary, Isaac Kinde, Yuxuan Wang +58 more
Science Translational Medicine 2014
5,035
High Frequency of Mutations of the <i>PIK3CA</i> Gene in Human Cancers
Yardena Samuels, Zhenghe Wang, Alberto Bardelli, Natalie Silliman, Janine Ptak +10 more
Science 2004
3,428

Publications

926 total

Early‐onset colorectal cancer in young individuals PDF

Gianluca Mauri, Andrea Sartore‐Bianchi, Antonio Russo, Silvia Marsoni, Alberto Bardelli et al. - Molecular Oncology, 2018
Cited by 660 OpenAlex

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

Giovanni Germano, Simona Lamba, Giuseppe Rospo, Ludovic Barault, Alessandro Magrì et al. - Nature, 2017
Cited by 624 OpenAlex

Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma PDF

Lipika Goyal, Supriya K. Saha, Leah Y. Liu, Giulia Siravegna, Ignaty Leshchiner et al. - Cancer Discovery, 2016
Cited by 535 OpenAlex

Toward understanding and exploiting tumor heterogeneity PDF

Ash A. Alizadeh, Victoria Aranda, Alberto Bardelli, Cédric Blanpain, Christoph Bock et al. - Nature Medicine, 2015
Cited by 763 OpenAlex

Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma PDF

Chong Sun, Liqin Wang, Sidong Huang, Guus J.J.E. Heynen, Anirudh Prahallad et al. - Nature, 2014
Cited by 904 OpenAlex

Amplification of the <i>MET</i> Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer PDF

Alberto Bardelli, Simona Corso, Andrea Bertotti, Sebastijan Hobor, Emanuele Valtorta et al. - Cancer Discovery, 2013
Cited by 662 OpenAlex

A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer PDF

Andrea Bertotti, Giorgia Migliardi, Francesco Galimi, Francesco Sassi, Davide Torti et al. - Cancer Discovery, 2011
Cited by 944 OpenAlex

Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

Wendy De Roock, Derek J. Jonker, Federica Di Nicolantonio, Andrea Sartore‐Bianchi, Dongsheng Tu et al. - JAMA, 2010
Cited by 746 OpenAlex

Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer

Alberto Bardelli, Salvatore Siena - Journal of Clinical Oncology, 2010
Cited by 743 OpenAlex

<i>PIK3CA</i> Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies

Andrea Sartore‐Bianchi, Miriam Martini, Francesca Molinari, Silvio Veronese, Michele Nichelatti et al. - Cancer Research, 2009
Cited by 737 OpenAlex

Research Topics

Colorectal Cancer Treatments and Studies (403) Cancer Genomics and Diagnostics (245) Genetic factors in colorectal cancer (173) Lung Cancer Treatments and Mutations (130) Cancer Research and Treatments (75)

Frequent Co-Authors

SA
Salvatore Siena
9 joint publications
AN
Andrea Sartore‐Bianchi
8 joint publications
FE
Federica Di Nicolantonio
8 joint publications
SI
Silvio Veronese
4 joint publications
MA
Marcello Gambacorta
3 joint publications
SI
Silvia Marsoni
3 joint publications

Affiliations

University of Pisa
IT 2024 - 2024
University of Verona
IT 2007 - 2007
Universitat Autònoma de Barcelona
ES 2014 - 2014
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
IT 2007 - 2007
Collegio Carlo Alberto
IT 2024 - 2019

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now